Johnson and Johnson Bone Putty Has Tendency to Catch Fire and Cause Serious Injury and Death
U.S. health regulators have issued a Class 1 recall of the Johnson & Johnson made bone putty as the putty has shown a high tendency to catch fire when coming into contact with electrosurgical cautery systems during surgery. Such categorization indicates high risk factors for serious injury, including death. While bone putty was designed to […]
Initial Conference in Pradaxa Multidistrict Litigation set for October 3, 2012
Boehringer Ingelheim is now facing Multidistrict litigation over its dangerous drug, Pradaxa. The Pradaxa litigation was assigned to Chief Judge, David R. Herndon of the Southern District of Illinois. To date, Case Managment Order No. 1, Initial Conference Order and Procedural Matters, setting the initial conference for 10/3/2012 01:30 PM in East St. Louis Courthouse; […]
Byetta data raises significant concerns regarding the drug’s effect on heart rhythm
In an effort to receive approval from the FDA for its new diabetes drug Bydureon, Amylin Pharmaceuticals deliberately concealed relevant information pertaining to heart – safety issues surrounding the drug. Even after such concerns were made public, Amylin went even further in attempting to hinder FDA access to data showing Bydureon’s pitfalls. The series of […]
J&J continued to sell Gynemesh and Prolift implants for 9 months after FDA said to cease marketing
Johnson & Johnson has recently come under intense scrutiny from consumers and doctors alike after it was discovered that it continued to sell a vaginal mesh implant (Gynecare Prolift) for nine months after U.S. regulators told the company to stop marketing the device. The implant, which surgeons thread through vaginal incisions to treat incontinence or […]
J&J continued to sell Gynemesh and Prolift implants for 9 months after FDA said to cease marketing
Johnson & Johnson has recently come under intense scrutiny from consumers and doctors alike after it was discovered that it continued to sell a vaginal mesh implant (Gynecare Prolift) for nine months after U.S. regulators told the company to stop marketing the device. The implant, which surgeons thread through vaginal incisions to treat incontinence or […]
STUDY CONFIRMS THE INCREASED RISK OF BLADDER CANCER WITH ACTOS (PIOGLITAZONE)
The British Medical Journal recently published results from a study providing evidence that Actos (pioglitazone), an oral antidiabetic agent in the thiazolidinedione class, is associated with an increased risk of bladder cancer. The cohort included 115,727 diabetics newly treated with oral hypoglycemic agents between 1988 and 2009. The study criteria excluded patients who were below […]
Case management in MDLs 2325 (AMS), 2326 (Boston Scientific), & 2327 (Ethicon)
Judge Goodwin’s Daybook Entries of May 24, 2012, contain a case management section applicable to the AMS, Boston Scientific and Ethicon vaginal mesh injury cases, and states: MDL Nos. 2325 (AMS), 2326 (Boston Scientific), and 2327 (Ethicon): • Direct Filling Order. • Protective Order; the Protective Order entered in the Bard MDL will be the […]
Status of MDL 2327 Ethicon Pelvic Repair Litigation
Judge Goodwin’s Daybook Entry of May 24, 2012 reflects that the following matters were discussed in the MDL 2327 Ethicon Pelvic Repair Litigation: • ESI Protocol: coordination with New Jersey document production. • Pltf and Deft Fact Sheets • Coordination of discovery with ongoing New Jersey discovery. • Number of examiners. • Foreign depositions. • […]
Status of MDL 2326 Boston Scientific Pelvic Repair Litigation
On May 24, 2012, Judge Goodwin’s Daybook Entries reflect that the following matters were discussed in the Boston Scientific vaginal mesh injury litigation: • Pending Motions to Dismiss. • Boston Scientific Corporations Request for Science Day. • Discussion of ESI Protocol, Pltf and Deft Fact Sheets, Coordination of Discovery with Massachusetts. Boston Scientific’s science day […]
Status of MDL 2325 American Medical Systems Pelvic Repair Litigation
At a regularly scheduled status conference on May 25, 2012, in the federal multi-district litigation status conference, Judge Goodwin noted the follwing in his Daybook Entry: MDL No. 2325: • AMS Request for Science Day; scheduled for July 26, 2012 @ 10:00 a.m. • Counsel for Boston Scientific Corp will be permitted to make a […]
